PubMed Health⌕ Search

Biomedical subjects

B Pokrić

Publications and source records attributed to B Pokrić.

21 records · Page 2Linked to original sources

Precipitation at equivalence and equilibrium: a method for the determination of equilibrium constants of reaction between multideterminant antigen and specific polyclonal antibodies.

A theoretical approach for the determination of the equilibrium constant, Ka, of the reaction between a multideterminant antigen (Ag) and specific polyclonal antibodies (Ab) forming the insoluble Ab/Ag immune complex, is derived. The constant can be expressed as a function of the two accessible experimental parameters, the precipitating concentration of the antigen and the Ab/Ag molar ratio. For this purpose Ab/Ag immune complex must be prepared at equivalence, and equilibrium between precipitated and soluble species must be reached. The proposed method is experimentally tested on the system human serum albumin (HSA) and polyclonal rabbit antibodies. The Ab/Ag precipitates are prepared by the direct mixing of biological fluids in which immunoreacting components naturally occur. Previous separation, purification, or labeling of immunoreacting components are not required. The conditions for the precipitation of Ab/Ag complexes at equivalence, the stoichiometric composition or the average number of Ab molecules bound to one Ag molecule, and the solubility of the immunoprecipitating components are determined by a rectangular two-dimensional double immunodiffusion. Since the solubility determined under the conditions of a double immunodiffusion is a result of the interaction of the global diffusion of the precipitating components and particle growth kinetics, it mostly refers to the dynamic conditions. To find the solubility under equilibrium conditions, it is sufficient to determine the minimal factor by which the solutions of both immunoprecipitating components should be diluted so that no precipitate is formed upon their mixing at equivalence. The dilution factor is determined by a measurement of the laser light scattering of the immunoprecipitating systems prepared with serially diluted Ag and Ab solutions.

Animals↗

Differentiation of infectious bursal disease viruses isolated in Croatia.

Infectious bursal disease viruses (IBDVs) in 26 IBDV-positive bursa samples collected in Croatia during the period 1996-2000 and in two commercially available vaccines were differentiated by the presence or absence of the CfoI, SacI, SspI, StuI, and TaqI restriction sites in the 422-bp fragment of segment A of the VP2 gene (nt 732-1153). The fragments from 14 (54%) field isolates were TaqI+ StuI+ SspI+ and SacI- CfoI-, indicating their very virulent (vv) character. The presence of CfoI restriction site in 10 (38%) field isolates is uncommon for vvIBDV strains. It was detected in only the 88180 vvIBDV strain. Nevertheless, these isolates can be classified as vv strains according to TaqI+ StuI+ SspI+ SacI- restrictions. Two SacI+ StuI+ CfoI+ TaqI- SspI- field isolates (8%) could be classified as non-vvIBDVs. The StuI+ restriction is common to vvIBDV strains. However, the StuI recognition sequence is present in the F52/70 classic European and 002-73 attenuated strains as well. The SacI+ CfoI+ StuI- SspI- restrictions and the lack of the TaqI restriction at nt position 832 show that the IBDV in GUMBOKAL IM-SPF vaccine corresponds to the attenuated and/or vaccine strains. The TaqI restriction at nt position 875 suggests that the IBDV in GUMBOKAL SPF vaccine could belong to the mild strains.

Animals↗

Tween 80-solubilized Newcastle disease virus prepared as a water-in-oil-in-water vaccine.

The Newcastle disease virus (NDV) was solubilized with 10% w/v Tween 80 and inactivated with 0.05% v/v formalin. The average molecular mass of the released antigenic subunits was 307 kD. The tested vaccine was prepared in the form of a water-in-oil-in-water emulsion (WOWE) vaccine. The oil-to-aqueous ratio was 1:2. The solubilized NDV was administered alone or built in a tetravalent WOWE vaccine. A dose of the monovalent vaccine containing an equivalent of 44.7 microliters of detergent-treated NDV-allantoic fluid (NDV-AF) was sufficient for the complete protection of the commercially available chickens vaccinated at the age of 5 wk and challenged 7 wk later. The anti-NDV-free chickens, vaccinated at 4 wk of age and challenged 2 wk postvaccination, were 100% and 73% protected by a vaccinal dose containing 178.6 and 89.3 microliters of detergent-treated NDV-AF, respectively. Commercially available light pullets, primary vaccinated with live lentogenic NDV vaccine, generated a protective level of NDV antibodies after revaccination with WOWE vaccine containing 89.3 microliters of detergent treated NDV-AF. Laying hens were revaccinated under field conditions at the beginning of the laying cycle by the tetravalent vaccine. A vaccinal dose/bird containing 11.2 microliters of detergent-treated NDV-AF elicited a long-lasting high level of NDV neutralizing antibodies.

Animals↗